This database was used to prospectively identify patients that were due for discharge. Discharge summaries that had been clinically screened by a pharmacist were reviewed for dispensing method, and documentation.
Further information about any changes between the drug history and the discharge summary was obtained from patients’; drug chart, which includes a medicines reconciliation section. Prescription items with the dispensing method “NPD” and “sufficient supply at home” medication were reviewed by checking the actual supply or discussion with patient, to ensure the patient had at least two weeks supply of medication. The discipline of the individual documenting medication changes in the discharge summary was also recorded. A maximum of three patients’; data per ward was collected. The above information would be recorded INK 128 molecular weight on a standardised data collection form and entered onto an Excel database for analysis. Ethics approval was not required as this is an audit. Data were collected for
141 patients being discharged during MDV3100 molecular weight the audit period. 34 of 141 patients (95%) were discharged with at least 2 weeks supply of their medication – either as a TTA supply, NPD supply, POD supply or sufficient supply at home. 1 of the remaining prescription items had “sufficient supply at home” but the patient had gone home by the time data were collected from the ward. Thus, it could not be confirmed if this was the case. Of the 6 patients that did not have 2 weeks supply, two of the items were inhalers – a Salbutamol 100 mcg inhaler and a Clenil modulite 100 mcg inhaler, and two patients were short of 2 weeks supply by a few tablets (12 tamoxifen 20 mg tablets and 10 finasteride 5 mg tablets). Two patients reported they had 5–6 days supply and
preferred to obtain more from the GP, whilst four patients only reported waiting for the supply to be made from the hospital.. Documentation of changes to medication on discharge varied for each patient, and was carried out by the doctors as well as the clinical pharmacists. 79 of the 141 patients (56%) had discharge summaries with complete documentation of all changes made to medication. 32 patients (23%) had no documentation of the medication changes. 26 patients (18%) had documentation of their medication changes on the discharge summary, but only partially. For example, changes to doses of regular medication would be documented but new medication would not be clearly documented. 4 patients had no drug history recorded and so it was unclear whether there were any medication changes to be documented. Documentation was carried out in parts by the discharging doctor and pharmacists across the bands. 100% of all discharge summaries for patients from the care of the elderly ward included documentation of all medication changes. It can be seen that both parameters – medication supply and discharge summary documentation – have area for improvement.